- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 392 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- November 2021
- 747 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 280 Pages
Global
From €2548EUR$2,800USD£2,165GBP
- Report
- June 2023
- 236 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- June 2023
- 245 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- December 2021
- 290 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Report
- December 2021
- 190 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2023
- 576 Pages
- Book
- January 2013
- 632 Pages
- Book
- February 2013
- 384 Pages

The Drug Delivery Technology market is a rapidly growing sector of the pharmaceutical industry. It encompasses a wide range of technologies and products that are used to deliver drugs to the body in a safe and effective manner. These technologies include oral, transdermal, inhalation, and injectable drug delivery systems. Drug delivery technologies are used to improve the efficacy of drugs, reduce side effects, and improve patient compliance.
The Drug Delivery Technology market is driven by the increasing demand for more effective and efficient drug delivery systems. This is due to the rising prevalence of chronic diseases, the need for personalized medicine, and the increasing demand for targeted drug delivery. Additionally, the development of new drug delivery technologies, such as nanotechnology, is expected to further drive the market.
Some of the major companies in the Drug Delivery Technology market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Other prominent players include GlaxoSmithKline, AstraZeneca, and Bayer. Show Less Read more